Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
27
Number of overlapping holdings
12.3%
% of IBBQ's 220 holdings also in IBRN
64.3%
% of IBRN's 60 holdings also in IBBQ
Overlap by Weight
Sector Drift (IBBQ minus IBRN)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBBQ |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
BIOGEN IDEC INC | 2.1% | 3.9% | 2.1% |
 |
ARGENX SE ADR | 1.9% | 4.2% | 1.9% |
|
INTRA-CELLULAR THERAPIES INC | 1.4% | 4.2% | 1.4% |
|
NEUROCRINE BIOSCIENCES INC | 1.2% | 4.2% | 1.2% |
|
SAREPTA THERAPEUTICS INC | 0.7% | 2.9% | 0.7% |
Position Highlights (Non-Overlapping Exposures)
IBBQ Overweight Relative to IBRN
|
VERTEX PHARMACEUTICALS INC | 8.5% |
|
AMGEN INC | 8.2% |
|
GILEAD SCIENCES INC | 8.1% |
|
REGENERON PHARMACEUTICALS | 7.1% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.4% |
|
ALNYLAM PHARMACEUTICALS INC | 3.6% |
 |
SANOFI-AVENTIS-ADR | 1.7% |
|
SUMMIT THERAPEUTICS INC | 1.5% |
|
INSMED INC | 1.5% |
|
UNITED THERAPEUTICS CORP | 1.4% |
IBBQ Underweight Relative to IBRN
|
CATALYST PHARMACEUTICAL PART | -4.7% |
|
PTC THERAPEUTICS INC | -3.9% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | -3.9% |
|
ACADIA PHARMACEUTICALS INC | -3.8% |
|
SCHOLAR ROCK HOLDING CORP. | -3.5% |
|
DENALI THERAPEUTICS INC. | -3.5% |
 |
ALKERMES PLC | -3.5% |
|
SUPERNUS PHARMACEUTICALS INC | -3.5% |
|
EDGEWISE THERAPEUTICS, INC. | -3.1% |
|
NEUROCRINE BIOSCIENCES INC | -3.1% |